NAC treatment reduced CDK5 activity, thereby decreasing DRP1 phosphorylation and preventing excessive mitochondrial fission
I suspect theres probably interesting second order implications to GLP-1 agonists impacting addiction behavior pathways or other biological systems that impact overdose response that are scientifically relevant
Circular RNA dysregulation is closely associated with malignant biological behavior in ovarian cancer cells
For weight management, NICE provides guidance on eligibility for specialist weight management services, which may include other pharmacological options such as orlistat (though this can also cause gastrointestinal side effects that may be problematic in IBD)
Pharma Compliance Mandate: State drug controllers and supply chain stakeholders are enforcing an immediate market recall, signaling a zero-tolerance policy for unvalidated drug formulations moving forward
Sinclair is co-founder of several biotechnology companies (Sirtris, Ovascience, Genocea, Cohbar, MetroBiotech, ArcBio, Liberty Biosecurity) and is on the boards of several others